Target intelligence / Profile preview

GATA binding protein 1 and GATA binding protein 2 (GATA-1 and GATA-2)

Target
GATA-1 and GATA-2
Molecular classification
Transcription factor, Zinc finger DNA-binding protein, GATA transcription factor
01

Overview

GATA-1 and GATA-2 are members of the GATA transcription factor family, characterized by two conserved zinc finger DNA-binding domains that recognize the "GATA" DNA motif. These proteins are essential regulators of hematopoietic cell development and differentiation, controlling gene expression through direct DNA binding and interactions with other transcriptional co-regulators and chromatin-modifying complexes. GATA-1 promotes erythroid and megakaryocyte differentiation and can both activate and repress target genes depending on context and partner protein interactions (such as with FOG-1 and the NuRD complex). GATA-2 is more widely expressed in stem and progenitor cells and is crucial for early hematopoiesis; its expression is tightly regulated, with GATA-1 participating in GATA-2 repression via chromatin remodeling and disruption of positive autoregulation. Both proteins are implicated in the pathogenesis of hematologic malignancies and developmental disorders, and mutations or abnormal expression can serve as clinically important biomarkers.

Other names
GATA family transcription factorsGATA1GATA2
02

Mechanism of action

Transcriptional modulation: Agents and mutations can cause activation or repression of GATA-1/2 target genes, often via chromatin remodeling or cofactor interactions (e.g., with FOG-1, NuRD complex).

03

Biological functions

Regulation of hematopoiesisControl of stem cell and progenitor cell functionRegulation of gene transcriptionCell differentiation
04

Disease associations

CancerHematologic malignanciesLeukemiaAcute megakaryoblastic leukemiaDevelopmental disordersDown syndrome-associated AMKLBreast cancerColorectal cancer
05

Safety considerations

Direct targeting risks disruption of normal hematopoiesis, as GATA-1 and GATA-2 are essential for stem cell function and differentiationMissense mutations can cause leukemogenesis and severe congenital anemias
06

Biomarkers

GATA mutationsGATA expression levelsBiomarker for acute megakaryoblastic leukemia (AMKL)Biomarker for Down syndrome-associated leukemiaBiomarker for breast cancerBiomarker for colorectal cancer

Beyond the preview

Go deeper on GATA binding protein 1 and GATA binding protein 2 (GATA-1 and GATA-2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GATA binding protein 1 and GATA binding protein 2 (GATA-1 and GATA-2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call